Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11071)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 27, 2015 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Schütte K, Schulz C, Link A, Malfertheiner P. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis. World J Hepatol 2015; 7(2): 139-149 [PMID: 25729470 DOI: 10.4254/wjh.v7.i2.139] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i2/139.htm |
| Number | Citing Articles |
| 1 |
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford, Chamindie Punyadeera. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188451 doi: 10.1016/j.bbcan.2020.188451
|
| 2 |
Andrea Martini, Andrea Gallotta, Patrizia Pontisso, Giorgio Fassina. Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C. World Journal of Hepatology 2015; 7(29): 2913-2919 doi: 10.4254/wjh.v7.i29.2913
|
| 3 |
Valérie Vilgrain, Bernard E. Van Beers, Catherine M. Pastor. Insights into the diagnosis of hepatocellular carcinomas with hepatobiliary MRI. Journal of Hepatology 2016; 64(3): 708 doi: 10.1016/j.jhep.2015.11.016
|
| 4 |
Weiyi Wang, Chao Wei. Advances in the early diagnosis of hepatocellular carcinoma. Genes & Diseases 2020; 7(3): 308 doi: 10.1016/j.gendis.2020.01.014
|
| 5 |
Nergis Ekmen, Çağri Akalin, Murat Akyildiz. Predictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidates. European Journal of Gastroenterology & Hepatology 2021; 32(2): 294 doi: 10.1097/MEG.0000000000001884
|
| 6 |
Mitsuro Kanda, Hiroyuki Sugimoto, Yasuhiro Kodera. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(37): 10584-10597 doi: 10.3748/wjg.v21.i37.10584
|
| 7 |
Chalermchai Pilapong, Sangsirin Siriwongnanon, Yanee Keereeta. Development of targeted multimodal imaging agent in ionizing radiation-free approach for visualizing hepatocellular carcinoma cells. Sensors and Actuators B: Chemical 2017; 245: 683 doi: 10.1016/j.snb.2017.02.012
|
| 8 |
Atieh Pourbagheri‐Sigaroodi, Fatemeh Fallah, Davood Bashash, Abdollah Karimi. Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC). Cell Biochemistry and Function 2024; 42(1) doi: 10.1002/cbf.3913
|
| 9 |
Francesca Angileri, Geneviève Morrow, Jean-Yves Scoazec, Nicolas Gadot, Vincent Roy, Suli Huang, Tangchun Wu, Robert M. Tanguay. Identification of circulating microRNAs during the liver neoplastic process in a murine model of hereditary tyrosinemia type 1. Scientific Reports 2016; 6(1) doi: 10.1038/srep27464
|
| 10 |
Yu-Cheng Zhang, Zhuo Xu, Tian-Fu Zhang, Ya-Li Wang. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(34): 9853-9862 doi: 10.3748/wjg.v21.i34.9853
|
| 11 |
Ioannis A. Ziogas, Georgios Sioutas, Konstantinos S. Mylonas, Georgios Tsoulfas. Role of MicroRNA in the Diagnosis and Management of Hepatocellular Carcinoma. MicroRNA 2019; 9(1): 25 doi: 10.2174/2211536608666190619155406
|
| 12 |
Qiuyue Hu, Shen Shen, Jianhao Li, Liwen Liu, Xin Liu, Yingying Zhang, Yongjian Zhou, Weiwei Zhu, Yan Yu, Guangying Cui. Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/3231273
|
| 13 |
Susanne Zweerink, Senait Mesghenna, Vera Mueck, Sigrid Schulte, Fabian Kuetting, Alexander Quaas, Tobias Goeser, Dirk Nierhoff. First evaluation of Neighbor of Punc E11 (NOPE) as a novel marker in human hepatocellular carcinoma. Cancer Biomarkers 2021; 30(1): 75 doi: 10.3233/CBM-190819
|
| 14 |
Xiao-Pin Ma, Guopeng Yu, Xubo Chen, Qianyi Xiao, Zhuqing Shi, Lu-Yao Zhang, Haitao Chen, Pengyin Zhang, Dong-Lin Ding, Hui-Xing Huang, Hexige Saiyin, Tao-Yang Chen, Pei-Xin Lu, Neng-Jin Wang, Hongjie Yu, Carly Conran, Jielin Sun, S. Lilly Zheng, Jianfeng Xu, Long Yu, De-Ke Jiang. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma. Tumor Biology 2016; 37(7): 9931 doi: 10.1007/s13277-016-4897-1
|
| 15 |
Ilvira M. Khan, Donjeta Gjuka, Jingjing Jiao, Xiaoling Song, Ying Wang, Jing Wang, Peng Wei, Hashem B. El-Serag, Jorge A. Marrero, Laura Beretta. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prevention Research 2021; 14(6): 667 doi: 10.1158/1940-6207.CAPR-20-0600
|
| 16 |
Yi Zhu, Jiang Zhu, Cong Lu, Qiushi Zhang, Wei Xie, Ping Sun, Xiaochuan Dong, Liang Yue, Yaoting Sun, Xiao Yi, Tiansheng Zhu, Guan Ruan, Ruedi Aebersold, Shi'ang Huang, Tiannan Guo. Identification of Protein Abundance Changes in Hepatocellular Carcinoma Tissues Using PCT–SWATH. PROTEOMICS – Clinical Applications 2019; 13(1) doi: 10.1002/prca.201700179
|
| 17 |
Pei-Pei Song, Ju-Feng Xia, Yoshinori Inagaki, Kiyoshi Hasegawa, Yoshihiro Sakamoto, Norihiro Kokudo, Wei Tang. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(1): 262-274 doi: 10.3748/wjg.v22.i1.262
|
| 18 |
Katarzyna Lubecka, Kirsty Flower, Megan Beetch, Jay Qiu, Lucinda Kurzava, Hannah Buvala, Adam Ruhayel, Samer Gawrieh, Suthat Liangpunsakul, Tracy Gonzalez, George McCabe, Naga Chalasani, James M Flanagan, Barbara Stefanska. Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development. Epigenetics 2018; 13(6): 605 doi: 10.1080/15592294.2018.1481706
|
| 19 |
Stefano Mazza, Chiara Frigerio, Daniele Alfieri, Aurelio Mauro, Francesca Torello Viera, Davide Scalvini, Chiara Barteselli, Carmelo Sgarlata, Letizia Veronese, Marco Bardone, Laura Rovedatti, Simona Agazzi, Elena Strada, Lodovica Pozzi, Marcello Maestri, Valentina Ravetta, Andrea Anderloni. Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative Treatment. Medicina 2024; 60(5): 692 doi: 10.3390/medicina60050692
|
| 20 |
Dhandhukiya Manavkumar Kanubhai, Saiyed Musaratafrin Sabirali. Hepatocellular Carcinoma: A Review. Asian Journal of Research in Pharmaceutical Sciences 2023; : 171 doi: 10.52711/2231-5659.2023.00030
|
| 21 |
Yu-Gui Zhang, Jiang-Tao Niu, Hong-Wei Wu, Xin-Lei Si, Shu-Juan Zhang, Dong-Hui Li, Tian-Tian Bian, Yue-Feng Li, Xing-Ke Yan, Matthias B. Stope. Actin-Binding Proteins as Potential Biomarkers for Chronic Inflammation-Induced Cancer Diagnosis and Therapy. Analytical Cellular Pathology 2021; 2021: 1 doi: 10.1155/2021/6692811
|
| 22 |
Krishana Kumar Sharma, Mohd. Mohsin, Piyush Mittal, Zeeshan Ali, Nishat Fatma, Prashant Upadhyay, Ritu Gupta, Anurag Verma, Gajendra Kumar. Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review. Current Pharmaceutical Design 2024; 30(22): 1708 doi: 10.2174/0113816128298875240321073907
|
| 23 |
Tong Wu, Na Li, Fengyuan Luo, Zhihong Chen, Liyuan Ma, Tao Hu, Guini Hong, Hongdong Li. Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs. BMC Bioinformatics 2023; 24(1) doi: 10.1186/s12859-023-05299-9
|
| 24 |
Francesco Bellissimo, Marilia Rita Pinzone, Bruno Cacopardo, Giuseppe Nunnari. Diagnostic and therapeutic management of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12003-12021 doi: 10.3748/wjg.v21.i42.12003
|
| 25 |
Saumya Madushani Samarasinghe, Asanka Sudeshini Hewage, Rohan Chaminda Siriwardana, Kamani Hemamala Tennekoon, Madunil Anuk Niriella, Sumadee De Silva. Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity. Egyptian Journal of Medical Human Genetics 2023; 24(1) doi: 10.1186/s43042-023-00433-x
|
| 26 |
Nobuhiro Tsuchiya, Yu Sawada, Itaru Endo, Keigo Saito, Yasushi Uemura, Tetsuya Nakatsura. Biomarkers for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(37): 10573-10583 doi: 10.3748/wjg.v21.i37.10573
|
| 27 |
Grace T. Kwok, Jing Ting Zhao, Jocelyn Weiss, Nancy Mugridge, Himanshu Brahmbhatt, Jennifer A. MacDiarmid, Bruce G. Robinson, Stan B. Sidhu. Translational applications of microRNAs in cancer, and therapeutic implications. Non-coding RNA Research 2017; 2(3-4): 143 doi: 10.1016/j.ncrna.2017.12.002
|
| 28 |
AA Mohamed, D Omran, S El-Feky, H Darwish, AEL Kassas, A Farouk, O Ezzat, SM Abdo, FE Zahran, A El-Demery, MM Omran. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index. British Journal of Biomedical Science 2021; 78(1): 18 doi: 10.1080/09674845.2020.1778842
|
| 29 |
Aly O. Aboelfotoh, Enas M. Foda, Ahmed M. Elghandour, Nahla M. Teama, Reham A. Abouzein, Ghada A. Mohamed. Talin-1; other than a potential marker for hepatocellular carcinoma diagnosis. Arab Journal of Gastroenterology 2020; 21(2): 80 doi: 10.1016/j.ajg.2020.04.017
|
| 30 |
Natalia Salinas Parra, Heather M. Ross, Adnan Khan, Marisa Wu, Risa Goldberg, Lokesh Shah, Sarah Mukhtar, Jacob Beiriger, Alexis Gerber, Dina Halegoua-DeMarzio. Advancements in the Diagnosis of Hepatocellular Carcinoma. International Journal of Translational Medicine 2023; 3(1): 51 doi: 10.3390/ijtm3010005
|
| 31 |
Vaneet Jearth, Prachi S. Patil, Shaesta Mehta, Sridhar Sundaram, Vishal Seth, Mahesh Goel, Shraddha Patkar, Munita Bal, Vidya Rao. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken. Journal of Clinical and Experimental Hepatology 2022; 12(3): 841 doi: 10.1016/j.jceh.2021.11.006
|
| 32 |
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
|
| 33 |
Chao Ye, Xiaoqian Zhang, Xinyu Chen, Qingyi Cao, Xiaobing Zhang, Yanwen Zhou, Wenxin Li, Liangjie Hong, Haiyang Xie, Xiaoli Liu, Hongcui Cao, Ying-Jie Wang, Bo Kang. Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4. Cellular Oncology 2020; 43(2): 279 doi: 10.1007/s13402-019-00487-3
|
| 34 |
A. Biasiolo, A. Martini, A. Gallotta, G. Fassina, P. Pontisso. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 559 doi: 10.1007/978-94-007-7675-3_15
|
| 35 |
Yiyu Lu, Zhaoyuan Fang, Meiyi Li, Qian Chen, Tao Zeng, Lina Lu, Qilong Chen, Hui Zhang, Qianmei Zhou, Yan Sun, Xuefeng Xue, Yiyang Hu, Luonan Chen, Shibing Su, Jiarui Wu. Dynamic edge-based biomarker non-invasively predicts hepatocellular carcinoma with hepatitis B virus infection for individual patients based on blood testing. Journal of Molecular Cell Biology 2019; 11(8): 665 doi: 10.1093/jmcb/mjz025
|
| 36 |
Jiatao Lou, LingFei Zhang, Shaogang Lv, Chenzi Zhang, Shuai Jiang. Biomarkers for Hepatocellular Carcinoma. Biomarkers in Cancer 2017; 9: 1179299X1668464 doi: 10.1177/1179299X16684640
|
| 37 |
Maissa El Raziky, Hanan Abdel Hafez, Aisha Elsharkawy, Tarek Ahmed Moneer, Suzan M. EL-Sheikh, Rabab M. Maher, Sahar A. Sharaf. Serum level of cytokeratin 19 as a diagnostic and prognostic marker in patients with HCV-related hepatocellular carcinoma. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00125-4
|
| 38 |
Fei Li, Ting Liu, Chun-Yang Xiao, Jing-Xia Yu, Lun-Gen Lu, Ming-Yi Xu. FOXP1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infection. Biomedicine & Pharmacotherapy 2015; 72: 103 doi: 10.1016/j.biopha.2015.04.006
|
| 39 |
A. Biasiolo, A. Martini, A. Gallotta, G. Fassina, P. Pontisso. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_15-1
|
| 40 |
Tian Hu, Jincheng Li, Chuhong Zhang, Xiu lv, Sai Li, Sha He, Hanxing Yan, Yixi Tan, Mingsheng Lei, Meiling Wen, Jianhong Zuo. The potential value of microRNA-4463 in the prognosis evaluation in hepatocellular carcinoma. Genes & Diseases 2017; 4(2): 116 doi: 10.1016/j.gendis.2017.03.003
|
| 41 |
Kashif Rafiq Zahid, Shiming Han, Fuling Zhou, Umar Raza. Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death. Cellular Oncology 2019; 42(1): 55 doi: 10.1007/s13402-018-0407-3
|
| 42 |
Jia H. Koh, Meng Wang, Hiroyuki Suzuki, Mark Muthiah, Cheng H. Ng, Daniel Q. Huang. NAFLD and NAFLD-related HCC in Asia: Burden and Surveillance. Journal of Clinical and Experimental Hepatology 2024; 14(1): 101213 doi: 10.1016/j.jceh.2023.06.013
|
| 43 |
Shicai Fan, Jianxiong Tang, Qi Tian, Chunguo Wu. A robust fuzzy rule based integrative feature selection strategy for gene expression data in TCGA. BMC Medical Genomics 2019; 12(S1) doi: 10.1186/s12920-018-0451-x
|
| 44 |
Martin Franck, Kerstin Schütte, Peter Malfertheiner, Alexander Link. Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors. World Journal of Gastroenterology 2020; 26(1): 86-96 doi: 10.3748/wjg.v26.i1.86
|
| 45 |
Nicole Golob-Schwarzl, Sonja Kessler, Johannes Haybaeck. Mechanisms of Molecular Carcinogenesis – Volume 2. 2017; : 119 doi: 10.1007/978-3-319-53661-3_6
|
| 46 |
Olfat Al-Harazi, Ibrahim H. Kaya, Maha Al-Eid, Lina Alfantoukh, Ali Saeed Al Zahrani, Mohammed Al Sebayel, Namik Kaya, Dilek Colak. Identification of Gene Signature as Diagnostic and Prognostic Blood Biomarker for Early Hepatocellular Carcinoma Using Integrated Cross-Species Transcriptomic and Network Analyses. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.710049
|
| 47 |
Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Maria Lorena Abate, Alessia Ciancio, Rinaldo Pellicano, Antonina Smedile, Giorgio Maria Saracco. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis. Scandinavian Journal of Gastroenterology 2018; 53(6): 734 doi: 10.1080/00365521.2018.1459824
|
| 48 |
Sania Safdar Butt, Khushbukhat Khan, Yasmin Badshah, Mehak Rafiq, Maria Shabbir. Evaluation of pro-apoptotic potential of taxifolin against liver cancer. PeerJ 2021; 9: e11276 doi: 10.7717/peerj.11276
|
| 49 |
Kashif Rafiq Zahid, Shun Yao, Abdur Rehman Raza Khan, Umar Raza, Deming Gou. mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silico. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01000
|
| 50 |
Patrick Pham, Voreak Suybeng, Mohamed Takka, Nelly Bosselut, Rodolphe Sobesky, Jocelyne Hamelin, Didier Samuel, Raphaël Saffroy, Antoinette Lemoine. Cirrhose et carcinome hépatocellulaire : diagnostic et suivi biologique. Revue Francophone des Laboratoires 2017; 2017(490): 64 doi: 10.1016/S1773-035X(17)30080-1
|
| 51 |
Niveditta Ramkumar, Jeffrey P. Jacobs, Richard B. Berman, Devin M. Parker, Todd A. MacKenzie, Donald S. Likosky, Anthony DiScipio, David J. Malenka, Jeremiah R. Brown. Cardiac Biomarkers Predict Long-term Survival After Cardiac Surgery. The Annals of Thoracic Surgery 2019; 108(6): 1776 doi: 10.1016/j.athoracsur.2019.04.123
|
| 52 |
Da Kim, Eun Cho, Kyung-Sang Yu, In-Jin Jang, Jung-Hwan Yoon, Taesung Park, Joo-Youn Cho. Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis. Cancers 2019; 11(10): 1497 doi: 10.3390/cancers11101497
|
| 53 |
Yunjin Go, Jestlin Tianthing Ng, Darren Wan-Teck Lim, Su Bin Lim. HepScope: CNN-based single-cell discrimination of malignant hepatocytes. Journal of Big Data 2024; 11(1) doi: 10.1186/s40537-024-01024-2
|
| 54 |
Wen Li, Ruosha Li, Qingxiang Yan, Ziding Feng, Jing Ning. Conditional concordance‐assisted learning under matched case‐control design for combining biomarkers for population screening. Statistics in Medicine 2023; 42(9): 1398 doi: 10.1002/sim.9677
|